Determining coronavirus disease 2019 (COVID-19) community incidence threshold for preoperative testing

Preprocedural testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) is frequently used to reduce perioperative morbidity and mortality during the pandemic. Such testing is resource intensive, and the relative benefits depend on local epidemiology. We propose a threshold of 20 per 100...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Judy, Wituik, Christopher, Al-Salem, Mohammed, Aljarbou, Alanoud, Dekker, Jonah, Karimi, Saba, Mertz, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671915/
https://www.ncbi.nlm.nih.gov/pubmed/35968708
http://dx.doi.org/10.1017/ice.2022.206
Descripción
Sumario:Preprocedural testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) is frequently used to reduce perioperative morbidity and mortality during the pandemic. Such testing is resource intensive, and the relative benefits depend on local epidemiology. We propose a threshold of 20 per 100,000 unlinked cases to activate such testing to optimize the yield and positive predictive value.

Ejemplares similares